All In Biotech

Drug Trial Radar · NCT06029426

Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 383 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

383

Actual

Start

Sep 20, 2023

Primary completion

Dec 3, 2024

Study completion Jan 15, 2025

Sponsor

Lead sponsor
Neumora Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double blind, placebo controlled, multi-center study to evaluate the effects of NMRA-335140 (formerly BTRX 335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days), and a 6-week Treatment Period (during which participants will receive either NMRA-335140 or placebo). At the completion of the 6-week Treatment Period, participants who complete the study, provide informed consent, and meet the eligibility criteria may enter an extension study (NMRA-335140 501).

Conditions

  • Major Depressive Disorder

Interventions

  • NMRA-335140Drug

    Participants will receive NMRA-335140 at a dose of 80 mg QD, orally

  • PlaceboDrug

    Placebo will be administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline to Week 6 in the Montgomery Asberg Depression Rating Scale (MADRS) total scoreTime frame: Baseline and up to Week 6

Locations

64 sites in 1 country. Site status is shown where the registry gives one.

  • Neumora Investigator Site

    Huntsville, Alabama

  • Neumora Investigator Site

    Phoenix, Arizona

  • Neumora Investigator Site

    Bentonville, Arkansas

  • Neumora Investigator Site-1

    Little Rock, Arkansas

  • Neumora Investigator Site

    Little Rock, Arkansas

  • Neumora Investigator Site

    Rogers, Arkansas

  • Neumora Investigator Site

    Bellflower, California

  • Neumora Investigator Site

    Garden Grove, California

  • Neumora Investigator Site

    Glendale, California

  • Neumora Investigator Site

    Imperial, California

  • Neumora Investigator Site

    Lafayette, California

  • Neumora Investigator Site

    Long Beach, California

  • Neumora Investigator Site

    Los Angeles, California

  • Neumora Investigator Site

    Oceanside, California

  • Neumora Investigator Site

    Orange, California

  • Neumora Investigator Site

    Riverside, California

  • Neumora Investigator Site

    San Jose, California

  • Neumora Investigator Site #1

    Sherman Oaks, California

  • Neumora Investigator Site

    Sherman Oaks, California

  • Neumora Investigator Site

    Temecula, California

  • Neumora Investigator Site

    Torrance, California

  • Neumora Investigator Site

    Colorado Springs, Colorado

  • Neumora Investigator Site

    Gainesville, Florida

  • Neumora Investigator Site

    Hallandale, Florida

  • Neumora Investigator Site

    Jacksonville, Florida

  • Neumora Investigator Site

    Lauderhill, Florida

  • Neumora Investigator Site

    Maitland, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami Lakes, Florida

  • Neumora Investigator Site

    Orlando, Florida

  • Neumora Investigator Site

    Tampa, Florida

  • Neumora Investigator Site

    Marietta, Georgia

  • Neumora Investigator Site

    Chicago, Illinois

  • Neumora Investigator Site

    Evanston, Illinois

  • Neumora Investigator Site

    Warrenville, Illinois

  • Neumora Investigator Site

    Boston, Massachusetts

  • Neumora Investigator Site

    Methuen, Massachusetts

  • Neumora Investigator Site

    Watertown, Massachusetts

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.